Pharmacy news
- 06/09/2020 Update to July 1 commercial formulary changes
- 05/04/2020 We're removing prior authorization requirements for infliximab products
- 04/30/2020 July 1, 2020 formulary changes
- 04/29/2020 Biosimilars preferred over Herceptin, Avastin and Rituxan
- 04/14/2020 Ranitidine recall
- 03/16/2020 We're working hard to reduce pharmacy wait times
- 12/23/2019: Flublok vaccine now covered for commercial members
- 10/28/2019: Jan. 1 commercial and Medicare formulary updates
- 09/06/2019: Michigan Medicaid formulary changes coming Oct. 1
- 07/30/2019: Step therapy added for select Medicare Part B drugs effective Oct. 1, 2019
- 07/03/2019: Medicaid formulary changes for select asthma drugs effective Aug. 1, 2019
- 04/29/2019: Commercial formulary updates coming July 1
- 01/02/2019: Reminder: Effective Jan. 1, step therapy added for Medicare Part B drugs
- 12/20/2018: Voluntary recall of amlodipine
- 12/19/2018: Medicare Part D Opioid Policies from CMS effective Jan. 1, 2019
- 10/31/2018: Recent and upcoming formulary changes
- 08/30/2018: Michigan Medicaid Formulary Changes coming Oct. 1
- 08/06/2018: Valsartan blood pressure medication recalled
- 06/12/2018: Opioids policy updated
- 05/07/2018: July 1 pharmacy and formulary changes
- 05/02/2018: Biosimilars preferred over Remicade®
- 04/04/2018: January formulary updates
- 03/19/2018: January formulary updates
- 12/20/2017: MQIC releases guidelines for opioid prescribing
- 12/13/2017: November formulary updates
- 11/14//2017: Pharmacy benefit changes for 2017 and 2018
- 11/02/2017: Medicaid common formulary changes as of Oct. 1, 2017
- 10/13/2017: Medicaid narrow pharmacy network as of Dec. 1
- 08/14/2017: Topical corticosteroid formulary changes
- 08/02/2017: Opioid coverage changes start Sept. 1
- 12/08/2017: Hyaluronic acid derivatives coverage change Jan. 1